27.2 F
Park Forest
Sunday, December 4, 2022
The Free Press Isn't Free. Like what you see? Please subscribe.

Apotex Corp. Issues Voluntary Nationwide Recall of Fluticasone Propionate Nasal Spray Due to Potential for Small Glass Particles

 Fluticasone Propionate Nasal Spray
(Image Provided)
Silver Spring, Maryland—(ENEWSPF)—June 1, 2018
Contact: Jordan Berman

Apotex Corp. is voluntarily recalling one (1) lot of Fluticasone Propionate Nasal Spray, USP, 50 mcg per spray, 120 Metered Sprays, to the consumer level. The Fluticasone Propionate Nasal Spray USP 50 mcg per spray 120 Metered Sprays has been found to contain small glass particles. The glass particles could block the actuator and impact the functionality of the pump. The issue was discovered through a customer complaint.

Risk Statement: There is a potential for patients to be exposed to the glass particles and mechanical irritation cannot be ruled out. Local trauma to the nasal mucosa might occur with use of the defective product. To date, Apotex Corp. has not received any  reports of adverse events related to recall.
Fluticasone Propionate Nasal Spray USP 50 mcg per spray 120 Metered Sprays is indicated for the treatment of seasonal and perennial allergic rhinitis and for the management of sinus pain and pressure associated with allergic rhinitis in patients 4 to 17 years of age The affected Fluticasone Propionate Nasal Spray USP 50 mcg per spray 120 Metered Sprays can be identified by the information in the table below: and on the product label:

NDC Lot
Number
Expiration
Date
Strength Configuration/Count
60505-0829-1 NJ4501 07/2020 50 mcg per
spray
120 Metered
Sprays
Carton containing 1 Bottle of 50
mcg per spray 120 Metered Sprays

The affected Fluticasone Propionate Nasal Spray, USP, 50 mcg per spray, 120 Metered Sprays was distributed nationwide to wholesalers and distributors.

Apotex Corp. has notified wholesalers/distributor by recall letter to arrange for return of any recalled product.

Consumers/wholesalers/retailers/hospitals/institutions with an existing inventory of the lot subject to this recall should stop use and distribution of the remaining units and quarantine immediately. Healthcare Professionals in your organization should be informed of this recall. If you have further distributed the recalled product, to the wholesale or retail level, please notify any accounts or additional locations which may have received the recalled product from you. For additional assistance, call GENCO Pharmaceutical Services, a subsidiary of FedEx Supply Chain (GENCO) at 1- 877-475-5863 (7:00am – 5:00pm, CST Monday thru Friday), to arrange for return of the product.

Customers with questions regarding this recall can contact Apotex Corp.  by phone-number 1-800-706-5575 (8:30am – 5:00pm, EST Monday thru Friday) or email address [email protected].  Customers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Source: www.fda.gov

Comments

Recent Articles

Stay Connected

3,843FansLike
1,263FollowersFollow
586SubscribersSubscribe

Local Advertisers

ENEWSPF NEWS ALERTS

Trending

Park Forest
clear sky
27.2 ° F
32.7 °
24.7 °
75 %
2.2mph
0 %
Mon
41 °
Tue
44 °
Wed
46 °
Thu
44 °
Fri
43 °

About Google Ads

The Google-supplied ads that appear on this website are not reviewed ahead of time and differ for each visitor. If anything offensive, inappropriate, or otherwise unwholesome appears, please notify us so we can take steps to block that specific advertiser. Email the URL or advertiser name to [email protected].